This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar

Amicus Therapeutics

An under-$10 stock in the biotechnology and drugs complex that's trading very close to triggering a near-term breakout trade is Amicus Therapeutics (FOLD), which is focused on the discovery, development and commercialization of a new class of orally administered, small molecule drugs, for the treatment of a range of human genetic diseases. This stock has been on fire so far in 2012, with shares up a whopping 75%.

>>5 Stocks Poised to Pop on Bullish Earnings

If you take a look at the chart for Amicus Therapeutics, you'll notice that for the last two months, this stock has been uptrending from a low of $4.50 to its recent high of $6.15 a share. During that uptrend, shares of FOLD have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed FOLD within range of triggering a near-term breakout trade.

Traders should now look for long-biased trades in FOLD once it manages to break out above some near-term overhead resistance at $6.15 with high volume. Look for a sustained move or close above $6.15 with volume that hits near or above its three-month average action of 838,068 shares. If that breakout triggers soon, then FOLD will setup to re-test or possibly take out its next significant overhead resistance levels at $6.89 to $7.29 a share. If those levels get taken out with volume, then FOLD could easily trade north of $8 a share in the near future.

Traders can look to buy FOLD off any weakness, and simply use a stop somewhere below its 200-day moving average of $5.31 a share. A better strategy might be to buy off strength once FOLD clears $6.15 a share with volume, and then use a stop just below $5.60 a share. I would look to add to either position once FOLD takes out $6.89 to $7.29 a share with heavy volume.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
MEMS $0.00 0.00%
ADNC $4.89 -0.41%
CYTX $0.14 0.07%
FOLD $5.44 3.00%
XRS $44.95 4.60%


Chart of I:DJI
DOW 16,084.98 +70.60 0.44%
S&P 500 1,871.79 +19.58 1.06%
NASDAQ 4,341.4630 +72.70 1.70%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs